Traders should monitor the stock price closely over the next few months; a sustained move above $1.00 could trigger a short-term rally, but failure to comply by October 2026 risks delisting and sharp downside. Consider position size and liquidity risks.
Price Chart
Executive Summary
RedHill Biopharma received a Nasdaq deficiency notice due to its ADSs trading below $1.00 for 30 consecutive business days. The company has until October 5, 2026, to regain compliance by closing at or above $1.00 for 10 consecutive days. Trading continues unaffected for now.
Key Facts
- Nasdaq notified RedHill Biopharma that its ADSs closed below $1.00 for 30 consecutive business days from February 20, 2026, to April 2, 2026.
- The company has 180 calendar days, until October 5, 2026, to regain compliance.
- Compliance will be achieved if the ADSs close at or above $1.00 for 10 consecutive business days before the deadline.
- Trading on Nasdaq Capital Market continues during the compliance period.
- Market capitalization is only $4M, indicating extreme financial vulnerability.
Financial Impact
High risk of delisting if share price does not recover, which could trigger forced selling, reduced liquidity, and loss of investor confidence.
Risk Factors
- Risk of delisting if the bid price does not recover by October 5, 2026.
- Low market cap and weak trading price increase vulnerability to volatility and investor abandonment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-002107 |
| Document: 0001178913-26-002107-index-headers.html | 0001178913-26-002107 |
| Document: 0001178913-26-002107-index.html | 0001178913-26-002107 |
| Document: 0001178913-26-002107.txt | 0001178913-26-002107 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $0.4550 | awaiting T+60 | — | $0.4230 (−7.03%) |
Oct 19, 2026 7d ago | 6-K | $0.5012 | awaiting T+60 | — | $0.4230 (−15.60%) |
Oct 19, 2026 7d ago | Press Release | $0.5012 | awaiting T+60 | — | $0.4230 (−15.60%) |
Oct 13, 2026 12d ago | 6-K | $0.4862 | awaiting T+60 | — | $0.4230 (+13.00%) |
Oct 13, 2026 12d ago | 424B5 | $0.4862 | awaiting T+60 | — | $0.4230 (+13.00%) |
Oct 7, 2026 19d ago | 6-K | $0.4740 | awaiting T+60 | — | $0.4230 (−10.76%) |
Sep 1, 2026 7w ago | 6-K | $0.8700 | awaiting T+60 | — | $0.4230 (−51.38%) |
Aug 31, 2026 8w ago | 6-K | $0.9000 | awaiting T+60 | — | $0.4230 (−53.00%) |
Aug 7, 2026 11w ago | 6-K | $0.6050 | awaiting T+60 | — | $0.4230 (−30.08%) |
Aug 6, 2026 11w ago | 6-K | $0.5810 | awaiting T+60 | — | $0.4230 (−27.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers